Medicale Corp.
MCLE
$0.45
-$0.02-4.26%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -43.01% | 9.15% | 9.41% | 73.77% | 121.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.01% | 9.15% | 9.41% | 73.77% | 121.84% |
| Operating Income | 43.01% | -9.15% | -9.41% | -73.77% | -121.84% |
| Income Before Tax | 34.20% | -19.01% | -23.53% | -90.16% | -121.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.20% | -19.01% | -23.53% | -90.16% | -121.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.20% | -19.01% | -23.53% | -90.16% | -132.53% |
| EBIT | 43.01% | -9.15% | -9.41% | -73.77% | -121.84% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 36.36% | -20.83% | -28.57% | -100.00% | -135.71% |
| Normalized Basic EPS | 35.00% | -20.00% | -22.22% | -100.00% | -122.22% |
| EPS Diluted | 36.36% | -20.83% | -28.57% | -100.00% | -135.71% |
| Normalized Diluted EPS | 35.00% | -20.00% | -22.22% | -100.00% | -122.22% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
